Vivlion
Pre-clinicalDelivering next-generation CRISPR screening and tailored CRISPR libraries for fast and efficient drug target discovery.
Founded
2020
Focus
CRISPRGenetics & GenomicsSynthetic Biology
About
Delivering next-generation CRISPR screening and tailored CRISPR libraries for fast and efficient drug target discovery.
Funding History
2Total raised: $16.3M
Series A$12MAndera PartnersMay 15, 2023
Seed$4.3MHigh-Tech GründerfondsSep 15, 2021
Company Info
TypePrivate
Founded2020
LocationRegensburg, Germany
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile